🧬Rare & Orphan Diseases
Market Cap$292.2B
1D-0.34%
Companies239
Public Cos75
SECTOR MARKET CAP
$292.2B+246.8%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United States | $24.2B | UTHR |
| 2 |  | United States | $22.8B | INSM |
| 3 |  | United Kingdom | $20.3B | ROIV |
| 4 |  | Sweden | $16.5B | SOBI.ST |
| 5 |  | France | $16.2B | IPN.PA |
| 6 |  | Denmark | $15.3B | ASND |
| 7 |  | Ireland | $14.2B | JAZZ |
| 8 |  | United States | $13.1B | BBIO |
| 9 |  | United States | $12.7B | IONS |
| 10 |  | Italy | $12.0B | REC.MI |
| 11 |  | United States | $10.7B | ARWR |
| 12 |  | United States | $10.5B | BMRN |
| 13 |  | United States | $9.3B | PRAX |
| 14 |  | United States | $8.8B | KRYS |
| 15 |  | Taiwan | $8.6B | 6446.TW |
| 16 |  | Japan | $7.8B | 4151.T |
| 17 |  | United States | $6.5B | RYTM |
| 18 |  | United States | $6.5B | MIRM |
| 19 |  | United States | $6.2B | BLTE |
| 20 |  | United States | $6.0B | COGT |